Skip to search formSkip to main contentSkip to account menu

ABT 492

Known as: ABT-492, ABT492 
National Institutes of Health

Related topics

Related topics

4 relations
ABT492:Susc:Pt:Isolate:OrdQn:MICWQ 3034

Broader (1)

Fluoroquinolones

Narrower (1)

delafloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Mutant Prevention Concentrations of ABT-492, Levofloxacin, Moxifloxacin, and Gatifloxacin against Three Common Respiratory Pathogens
ABSTRACT The purpose of this study was to compare the mutant prevention concentration (MPC) of ABT-492 to those of levofloxacin… 
2005
2005
Comparative pharmacodynamics of the new fluoroquinolone ABT492 and levofloxacin with Streptococcus pneumoniae in an in vitro dynamic model.
2004
2004
ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model.
OBJECTIVE To compare the kinetics of killing/regrowth of differentially susceptible clinical isolates of Staphylococcus aureus… 
2004
2004
Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
2004
2004
ABT‐492: Quinolone Antibacterial
A8T-492/WQ-3034 is a novel fluoroquinolone that targets bacterial DNA topoisomerases and is undergoing clinical evaluation for… 
2003
2003
Comparative In Vitro Susceptibilities and Bactericidal Activities of Investigational Fluoroquinolone ABT-492 and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas
ABSTRACT We determined in vitro susceptibilities for ABT-492 and other antimicrobials against Mycoplasma pneumoniae, Mycoplasma… 
2003
2003
Determination of in vitro susceptibility to ABT-492 by BSAC standardized methodology.
Sir, ABT-492 is a new quinolone currently under development by Abbott Laboratories (Abbott Park, IL, USA) that has been shown to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)